Recombinant Anti-CD3 x Anti-TPBG Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD3 antibody variable domain are respectively connected to the N terminus of the anti-TPBG IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Renal cell cancer (RCC); Non-small lung cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD3 x Human Anti-TPBG Bispecific Antibody (scFv-IgG) (BSSG-H282). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS